UAMC 00039 dihydrochloride
CAS No. 697797-51-6
UAMC 00039 dihydrochloride( UAMC00039, UAMC 00039, UAMC-00039 )
Catalog No. M17570 CAS No. 697797-51-6
UAMC00039 dihydrochloride is a potent, reversible and competitive dipeptidyl peptidase II inhibitor with an IC50 of 0.48 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 69 | In Stock |
|
| 5MG | 91 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 332 | In Stock |
|
| 50MG | 494 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUAMC 00039 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionUAMC00039 dihydrochloride is a potent, reversible and competitive dipeptidyl peptidase II inhibitor with an IC50 of 0.48 nM.
-
DescriptionUAMC 00039 dihydrochloride is a potent inhibitor of dipeptidyl peptidase II (DPP-II) (IC50 = 0.48 nM). UAMC 00039 dihydrochloride exhibits selectivity for DPP-II against DPP-9, DPP-8 and DPP-IV (IC50 values are 78.6, 142 and 165 μM, respectively).
-
In VitroUAMC00039 has an IC50 of 0.48±0.04 nM and a high selectivity for DPPII compared to DPPIV (IC50=165±9 μM) and DPP activity not caused by DPPII or DPPIV. UAMC00039 seems a promising tool to unravel the function of DPPII as well as to validate its potential as a therapeutic target. The efficacy of a DPPII inhibitor in cell culture depends not only on the inhibitors’ potency towards the enzyme but also on its stability in the medium and its ability to enter the cell. UAMC00039 is stable for at least 48 h at 37 °C in culture medium and in DPPII assay buffer. The compound is able to enter PBMC within 1 min resulting in a concentration-dependent inhibition of intracellular DPPII activity without affecting the ‘non-DPPII’ DPP activity. 1 and 100 μM UAMC00039 inhibits DPPII activity of PBMC and U937 cells more than 90%.
-
In VivoA dose dependent inhibition of DPPII but not of DPPIV is observed in the peripheral organs of both the rats and the mice (after oral administration) and the rabbits (after IV administration). UAMC00039 tested orally at 2 mg/kg does not cause signs of acute toxicity and does not cause any significant changes in the following functions that are evaluated: general behaviour, body temperature, respiration, bleeding time, blood pressure, urine volume, liver function, fasting glucose and gastrointestinal parameters like acidity, motility and irritation.
-
SynonymsUAMC00039, UAMC 00039, UAMC-00039
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorDipeptidyl peptidase II
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number697797-51-6
-
Formula Weight382.76
-
Molecular FormulaC16H26Cl3N3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 150 mg/mL; 391.89 mM
-
SMILESC1CCN(CC1)C(=O)[C@H](CCNCc1ccc(cc1)Cl)N.Cl.Cl
-
Chemical Name(2S)-2-Amino-4-[[(4-chlorophenyl)methyl]amino]-1-(1-piperidinyl)-1-butanone dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maes MB, et al. In vivo effects of a potent, selective DPPII inhibitor: UAMC00039 is a possible tool for the elucidation of the physiological function of DPPII. Adv Exp Med Biol. 2006;575:73-85.
molnova catalog
related products
-
Cu(II)-Elesclomol
Cu(II)-Elesclomol is a complex formed by the anticancer agent Elesclomol and Cu(II), which selectively transports copper to mitochondria.Cu(II)-Elesclomol has anticancer activity, inhibits the growth of human leukemia K562 cells, and induces cell-cycle arrest, and is used in the study of leukemias.
-
Indotecan
Indotecan is an effective inhibitor of topoisomerase 1(Top1).
-
Pirarubicin
Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into Dna and interacts with topoisomerase II, used as an antineoplastic agent.
Cart
sales@molnova.com